MEditerranean LIfestyle in Pediatric Obesity Prevention (MELI-POP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04597281 |
|
Recruitment Status :
Recruiting
First Posted : October 22, 2020
Last Update Posted : October 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Obesity, Childhood | Other: Lifestyle intervention | Not Applicable |
Hypothesis A healthy lifestyle, based on the promotion of the Mediterranean dietary pattern and regular physical activity, decrease the likelihood of developing obesity and cardio-metabolic abnormalities during childhood and adolescence.
Objectives
To assess, in a cohort of children at high risk of obesity, if an intervention during childhood and adolescence, considering a healthy lifestyle based on the promotion of Mediterranean dietary pattern and regular physical activity, when compared with a control group Main objective
- To decrease obesity incidence 5 and 10 years after the start of the intervention Secondary objectives
- To improve body composition (Body mass index z-score, Fat mass index z-score, waist circumference) assessed in a yearly basis
- To improve health-related physical fitness assessed in a yearly basis
- To improve cardiovascular risk factor (classic and omics) associated with obesity 1, 3, 5 and 10 years after the start of the intervention Intermediary objectives
- To increase the adherence to a Mediterranean dietary pattern 1, 3, 5 and 10 years after the start of the intervention
- To increase the adherence to age-specific physical activity recommendations 1, 3, 5 and 10 years after the start of the intervention
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 738 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | MEditerranean LIfestyle in Pediatric Obesity Prevention |
| Actual Study Start Date : | March 1, 2018 |
| Estimated Primary Completion Date : | June 30, 2022 |
| Estimated Study Completion Date : | December 31, 2032 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Mediterranean lifestyle
Mediterranean lifestyle, including dietary advice and physical activity advice. In addition, families receive extra-virgin olive oil and fish and two sessions of physical activity per week, for free.
|
Other: Lifestyle intervention
The intervention group, will receive education on Mediterranean lifestyle (Mediterranean diet and physical activity promotion), combined with the provision of extra-virgin olive oil and fish, in order to be consumed at least 3 times per week. Physical activity sessions with a physical activity monitor will also be offered for free to the children (2 sessions of 60 minutes of moderate-vigorous physical activity, per week) |
|
No Intervention: Usual care
General care by their pediatricians.
|
- Incidence of obesity [ Time Frame: 10 years ]Number of children having normal-weight at the baseline measurement and having obesity at follow-up.
- Body composition [ Time Frame: 10 years ]Fat mass index assessed using skinfold thickness measurements.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 3 Years to 7 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Children > 3 years and < 7 years, with at least one parent having a BMI ≥ 25 kg/m2, with no disease responsible for the high BMI.
- Children with normal- or over weight, following the IOTF criteria (Cole TJ, Lobstein T. Pediatr Obes 2012; 7: 284-294).
Exclusion Criteria:
- Children < 3, or > 7 yearss, or both parents Having BMI <25 kg/m2.
- Children with chornic diseases or following a therapeutic diet .
- Children from families having dietary habits not fitting with the characteristics of the dietary intervention.
- Children from families having difficulties to follow the protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04597281
| Contact: Luis A Moreno Aznar, MD, PhD | +34976761000 ext 4457 | lmoreno@unizar.es |
| Spain | |
| Instituto Maimónides de Investigación Biomédica de Córdoba | Recruiting |
| Córdoba, Spain, 14004 | |
| Contact: María Mercedes Gil Campos, MD, PhD +34957213700 mercedes_gil_campos@yahoo.es | |
| Fundación del Instituto de Investigación Sanitaria de Santiago | Recruiting |
| Santiago De Compostela, Spain, 15706 | |
| Contact: María Rosaura Leis Trabazo, MD, PhD +34981955308 mariarosaura.leis@usc.es | |
| Instituto de Investigación Sanitaria Aragón | Recruiting |
| Zaragoza, Spain, 50009 | |
| Contact: Luis A Moreno aznar, MD. PhD +34976761000 ext 4457 lmoreno@unizar.es | |
| Principal Investigator: | Luis A Moreno Aznar, MD, PhD | Universidad de Zaragoza |
| Responsible Party: | Luis A. Moreno Aznar, Professor, Universidad de Zaragoza |
| ClinicalTrials.gov Identifier: | NCT04597281 |
| Other Study ID Numbers: |
PI18/00666 |
| First Posted: | October 22, 2020 Key Record Dates |
| Last Update Posted: | October 22, 2020 |
| Last Verified: | October 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | The plan is to allow other researchers to use the data obtained in the study is this is approved byut the corresponding responsible persons. |
| Supporting Materials: |
Study Protocol Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code |
| Time Frame: | At the end of the trial |
| Access Criteria: | Approval of an analysis protocol by the study's steering committee |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Obesity Pediatric Obesity Overnutrition |
Nutrition Disorders Overweight Body Weight |

